- Home
- UNP vs PFE Comparison
UNP vs PFE Comparison
Compare UNP & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNP
- PFE
- Stock Information
- Founded
- UNP 1862
- PFE 1849
- Country
- UNP United States
- PFE United States
- Employees
- UNP N/A
- PFE N/A
- Industry
- UNP Railroads
- PFE Biotechnology: Pharmaceutical Preparations
- Sector
- UNP Industrials
- PFE Health Care
- Exchange
- UNP Nasdaq
- PFE Nasdaq
- Market Cap
- UNP 147.6B
- PFE 166.8B
- IPO Year
- UNP N/A
- PFE N/A
- Fundamental
- Price
- UNP $242.37
- PFE $25.63
- Analyst Decision
- UNP Buy
- PFE Buy
- Analyst Count
- UNP 20
- PFE 13
- Target Price
- UNP $259.80
- PFE $33.17
- AVG Volume (30 Days)
- UNP 2.6M
- PFE 55.0M
- Earning Date
- UNP 10-24-2024
- PFE 10-29-2024
- Dividend Yield
- UNP 2.21%
- PFE 6.55%
- EPS Growth
- UNP 4.44
- PFE N/A
- EPS
- UNP 10.88
- PFE 0.74
- Revenue
- UNP $24,288,000,000.00
- PFE $59,375,000,000.00
- Revenue This Year
- UNP $1.50
- PFE $8.76
- Revenue Next Year
- UNP $3.79
- PFE $0.37
- P/E Ratio
- UNP $22.28
- PFE $34.46
- Revenue Growth
- UNP 0.61
- PFE N/A
- 52 Week Low
- UNP $218.55
- PFE $24.48
- 52 Week High
- UNP $258.66
- PFE $31.54
- Technical
- Relative Strength Index (RSI)
- UNP 56.09
- PFE 36.44
- Support Level
- UNP $231.84
- PFE $24.61
- Resistance Level
- UNP $241.09
- PFE $26.85
- Average True Range (ATR)
- UNP 4.38
- PFE 0.62
- MACD
- UNP 0.47
- PFE -0.11
- Stochastic Oscillator
- UNP 57.92
- PFE 32.67
About UNP Union Pacific Corporation
Omaha, Nebraska-based Union Pacific is the largest public railroad in North America. Operating on more than 30,000 miles of track in the western two thirds of the us, UP generated $24 billion of revenue in 2023 by hauling coal, industrial products, intermodal containers, agriculture goods, chemicals, fertilizers, and automotive goods. UP owns about one fourth of Mexican railroad Ferromex and historically derives roughly 10% of its revenue hauling freight to and from Mexico.
About PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.